StockTipsArenaBeta

BUY Orchid Pharma Limited — Rajesh Satpute

BUYOrchid Pharma Limited

byRajesh SatputeHorizon: NA (inferred Swing (≤2wk))9 Sept 2026via CNBC Awaaz.

Entry₹1,025.8Inferred
Target₹1,060
Total upside +3.33% (call closed)
Stop loss₹1,010-1.54% risk
Exit₹1,01010 Sept 2026, 10:00 am
Stop-loss hit-1.54%
Follow Rajesh Satpute for new calls(30% target hit, 144 closed calls)Get alertsWatch ORCHPHARMA for new buy/sell callsGet alertsSee 276 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 10 Sept, 1:38 pm IST
1 supporting1 neutral0 opposing
Supports the BUY call (1)

1 advisor has an active short-term BUY call on this stock

Advisor consensus · adjacent horizon·8 Jul · 2mo ago

Neutral / worth noting (1)

Orchid Pharma Limited's Board Meeting on Sep 03, 2026, approved the appointment of Cost Auditors for FY 2026-27 and Mr. Arjun Dhanuka as Whole-Time Director. The meeting also set dates for the 33rd AG

NSE · Outcome of Board Meeting·3 Sept · 6d ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.